leisure time -WSS

leisure time

author：comprehensive 2025-10-02 22:56:58 - browse：84

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： AI used to predict Covid

focus

WSS

Addiction doctors spar with methadone clinics over legislation

Meta looks to target Twitter with a rival app called Threads

Grail is spending more than ever lobbying Congress

Focused ultrasound for uterine fibroids: an uphill battle

Connecting traumatic brain injury and domestic violence

7 people shot in DC, police say

leisure time

leisure time

knowledge

Walensky prepares to leave CDC — and Congress — behind

What will save rural psychiatry services? Higher Medicaid payments

Moonlake's readout produced a cash windfall. Risks remain

iTeos Therapeutics debuts first data on TIGIT

Peter Hotez and the public health issue of online harassment

Bacterial infection may be ‘key event’ in endometriosis, study says

Heart attack and stroke risk calculators need revising

Can food be medicine? And other questions about a new push

State Dept. review finds Biden bears some blame for Afghanistan failures

7 people shot in DC, police say

knowledge

A new study asks: Are we harming blood donors by taking blood?

Dark money group runs ads on China biotech bill

Grail is spending more than ever lobbying Congress

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

New case study details death in closely watched Alzhiemer's trial

hotspot

focus

explore

Wikipedia